PCM
Perkins Capital Management Portfolio holdings
AUM
$126M
1-Year Est. Return
67.67%
This Fund
S&P 500
1 Year Est. Return
+67.67%
AUM
$126M
AUM Growth
+$12.5M
(+11%)
Holding
92
Top Buys
| 1 | +$1.16M | |
| 2 | +$1.13M | |
| 3 | +$944K | |
| 4 |
PROF
Profound Medical
PROF
|
+$734K |
| 5 |
CPS Technologies
CPSH
|
+$715K |
Top Sells
| 1 | +$1.83M | |
| 2 | +$632K | |
| 3 | +$601K | |
| 4 |
Hain Celestial
HAIN
|
+$335K |
| 5 |
OptimizeRx
OPRX
|
+$330K |
Sector Composition
| 1 | Healthcare | 64.31% |
| 2 | Technology | 24.24% |
| 3 | Communication Services | 5.8% |
| 4 | Industrials | 2.52% |
| 5 | Consumer Staples | 1.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Inuvo
INUV
$38.5M
| $1.45M | 1.15% |
585,291
-85,681
|
|
||
27
AbbVie
ABBV
$415B
| $1.33M | 1.06% |
5,842
|
|
||
28
Perion Network
PERI
$347M
| $1.33M | 1.05% |
138,375
+15,425
|
|
||
29
Backblaze
BLZE
$221M
| $1.3M | 1.03% |
278,775
-1,250
|
|
||
30
Apple
AAPL
$3.86T
| $1.26M | 1% |
4,650
|
|
||
31
Crexendo
CXDO
$185M
| $1.26M | 1% |
194,850
+26,000
|
|
||
32
Neogen
NEOG
$2.38B
| $1.25M | 0.99% |
+179,250
|
|
||
33
Lucid Diagnostics
LUCD
$187M
| $1.23M | 0.97% |
1,126,000
-1,000
|
|
||
|
VELO
34
Velo3D Inc
VELO
$272M
| $1.2M | 0.95% |
87,000
+17,000
|
|
||
35
Zeta Global
ZETA
$4.11B
| $1.15M | 0.91% |
56,500
-1,000
|
|
||
36
NeuroOne Medical Technologies
NMTC
$33.4M
| $1.12M | 0.89% |
1,473,000
+5,000
|
|
||
37
Castle Biosciences
CSTL
$849M
| $1.09M | 0.87% |
28,045
-100
|
|
||
38
AtriCure
ATRC
$1.53B
| $1.09M | 0.86% |
27,450
-300
|
|
||
39
Gilead Sciences
GILD
$186B
| $1.01M | 0.81% |
8,266
|
|
||
40
Usio Inc
USIO
$38M
| $960K | 0.76% |
705,932
-152,261
|
|
||
41
Pfizer
PFE
$156B
| $929K | 0.74% |
37,309
-1,700
|
|
||
42
Merck
MRK
$304B
| $921K | 0.73% |
8,750
|
|
||
|
PROF
43
Profound Medical
PROF
$278M
| $899K | 0.71% |
+114,280
|
|
||
44
Codexis
CDXS
$92.1M
| $863K | 0.69% |
529,500
+221,800
|
|
||
45
Veritone
VERI
$259M
| $817K | 0.65% |
+175,600
|
|
||
46
Day One Biopharmaceuticals
DAWN
$1.06B
| $783K | 0.62% |
84,000
+1,750
|
|
||
47
Viatris
VTRS
$17.1B
| $721K | 0.57% |
57,895
+200
|
|
||
48
US Bancorp
USB
$84.1B
| $670K | 0.53% |
12,550
-350
|
|
||
49
ANI Pharmaceuticals
ANIP
$1.7B
| $666K | 0.53% |
8,441
|
|
||
50
Celcuity
CELC
$5.04B
| $638K | 0.51% |
6,400
-1,500
|
|